Annales de cardiologie et d'angeiologieHumansRituximabFemaleMiddle AgedPemphigoid
[Complications thromboemboliques après un traitement par rituximab chez une patiente atteinte de pemphigoïde bulleuse : un cas clinique].
Nouhaila Wakil, Lamia Tlohi, Meryem Haboub, Rachida Habbal
Published: 202510.1016/j.ancard.2025.101957
Abstract
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third leading cause of cardiovascular mortality worldwide, following stroke and myocardial infarction. Rituximab, a monoclonal antibody targetin…
Preview only. Read the full abstract at the source